Live Quote · NASDAQMNKDHealthcare· Biotechnology

MannKind Corporation

$3.85▼ 2.53%($-0.10)
MKT CAP $1.24BNEXT EARNINGS Feb 25, 2027
50%
Bullish
TickerSpark Score
64/100
▌ Mixed
70
Valuation
60
Profitability
50
Growth
60
Health
80
Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a MNKD research report →

Analyst Price Target
$11.00+185.7% vs. today

Range $10 – $13

Analyst RatingBuy
11 Buy3 Hold7 Sell

Price Chart

-22.54% · this period
$6.21$4.25$2.28Nov 20May 26Nov 20
52-Week Range38% of range
Low
$2.23
Current
$3.85
High
$6.51